Frontlight ResearchEarly access
Childhood cancers trials in China
609 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleZanubrutinib and Lenalidomide as Maintenance Therapy in DLBCL
- Where
- Beijing
- Age
- 14 years and over
- People
- 240
- Run by
- Navy General Hospital, Beijing
See details and how to joinNCT06503263 - Phase 1/2Taking peopleClinical Study on the Safety and Efficacy of CD7 CAR-T Cell in Patients With Relapsed/Refractory Acute Leukemia
- Where
- Chengdu
- Age
- 14 years to 65 years
- People
- 200
- Run by
- The General Hospital of Western Theater Command
See details and how to joinNCT06585345 - No phaseTaking peopleIndividualized Tumor-Informed CtDNA Analysis for Monitoring Postoperative Recurrence in ESCC (NEOCRTEC2401)
- Where
- Guangzhou
- People
- 50
- Run by
- Sun Yat-Sen University Cancer Center
See details and how to joinNCT06561178 - No phaseTaking peopleAdding Of Naxitamb In Induction Therapy For High Risk Neuroblastoma
- Where
- Guanzhou
- Age
- 1 year to 21 years
- People
- 64
- Run by
- Guangzhou Women and Children's Medical Center
See details and how to joinNCT06574698 - No phaseTaking peopleHypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer
- Where
- Shanghai
- People
- 428
- Run by
- Changhai Hospital
See details and how to joinNCT06325995 - Phase 2Taking peopleA Study of KC1036 in Adolescents With Advanced Ewing Sarcoma
- Where
- Beijing
- Age
- 12 years to 18 years
- People
- 30
- Run by
- Beijing Konruns Pharmaceutical Co., Ltd.
See details and how to joinNCT06564272 - Phase 2Taking peopleClinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML
- Where
- Beijing, Changsha, Guangzhou, Hefei, Jinan, Kaifeng, Nanning, Shanghai, Suzhou, Xuzhou, Zhengzhou
- Age
- Up to 18 years
- People
- 500
- Run by
- Children's Hospital of Soochow University
See details and how to joinNCT06221683 - Phase 2Taking peopleSafety and Efficacy of Avapritinib in Relapsed or Refractory Pediatric CBF-AML With KIT Mutation
- Where
- Changsha, Guangzhou, Hefei, Jinan, Kaifeng, Nanning, Shanghai, Suzhou, Xuzhou, Zhengzhou
- Age
- Up to 18 years
- People
- 50
- Run by
- Children's Hospital of Soochow University
See details and how to joinNCT06316960 - Phase 2/3Enrolling by invitationVenetoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients
- Where
- Suzhou
- People
- 98
- Run by
- The First Affiliated Hospital of Soochow University
See details and how to joinNCT06544109 - No phaseTaking peopleRET Inhibitor for Neoadjuvant Therapy in Locally Advanced RET-altered Thyroid Cancer
- Where
- Shanghai
- Age
- 14 years to 80 years
- People
- 48
- Run by
- Fudan University
See details and how to joinNCT06530316 - No phaseTaking peopleReal-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer
- Where
- Shanghai
- People
- 1,000
- Run by
- Fudan University
See details and how to joinNCT06503380 - No phaseNot yet taking people in ChinaResearch of the Application of Artificial Intelligence Model "PANDA"
- Where
- Hangzhou
- People
- 200,000
- Run by
- Zhejiang University
See details and how to joinNCT06528223 - Phase 2Taking peopleClinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma.
- Where
- Guangzhou
- Age
- 2 years to 21 years
- People
- 110
- Run by
- Yizhuo Zhang
See details and how to joinNCT06514313 - No phaseNot yet taking people in ChinaEarly Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures
- Where
- Hangzhou
- People
- 3,000
- Run by
- Zhejiang University
See details and how to joinNCT06495749 - No phaseTaking peoplePrognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics
- Where
- Xi'an
- Age
- 3 years to 80 years
- People
- 25,000
- Run by
- First Affiliated Hospital Xi'an Jiaotong University
See details and how to joinNCT06001073 - No phaseTaking peopleCharacteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE)
- Where
- Xi'an
- Age
- 3 years to 80 years
- People
- 40
- Run by
- First Affiliated Hospital Xi'an Jiaotong University
See details and how to joinNCT06100328 - No phaseTaking peopleMRD Response-adapted Allo-HSCT for Adverse-risk AML
- Where
- Beijing
- Age
- 16 years to 65 years
- People
- 178
- Run by
- Peking University People's Hospital
See details and how to joinNCT06301425 - Phase 2Not yet taking people in ChinaEffectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic Diseases
- Where
- Hefei
- People
- 39
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT06480630 - No phaseTaking peopleDiagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal Carcinoma
- Where
- Fuzhou, Guangzhou, Nanning, Wuzhou, Zhongshan
- People
- 908
- Run by
- Sun Yat-sen University
See details and how to joinNCT06445088 - Phase 2Taking peopleAnti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies
- Where
- Hong Kong
- Age
- 1 year and over
- People
- 20
- Run by
- Chi Kong Li
See details and how to joinNCT06462248 - Phase 1/2Taking peopleEffectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen
- Where
- Guangzhou
- Age
- 1 year to 18 years
- People
- 82
- Run by
- Sun Yat-sen University
See details and how to joinNCT06456892 - Phase 3Not yet taking people in ChinaCompare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR
- Where
- Shanghai
- Age
- 16 years to 65 years
- People
- 220
- Run by
- Ruijin Hospital
See details and how to joinNCT06297772 - No phaseTaking peopleEstablishing Prospective Mediastinal Tumor Database of PUMCH
- Where
- Beijing
- People
- 2,000
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06421805 - Phase 4Taking peopleBelimumab After Rituximab in Resistant Primary Juvenile SS
- Where
- Beijing
- Age
- 5 years to 18 years
- People
- 15
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT06410833 - Early phase 1Not yet taking people in ChinaClinical Study of Allogeneic Vγ9Vδ2 T Cells in the Treatment of Brain Malignant Glioma
- Where
- Beijing
- Age
- 4 years and over
- People
- 25
- Run by
- Beijing Tiantan Hospital
See details and how to joinNCT06396481